All In MedTech

FDA Clearance Tracker · P100045-S076

CardioMEMS HF System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 29, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 29, 2024

Approved

Time to decision

136 days

Received Apr 15, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100045-S076
Device name
CardioMEMS HF System
Applicant location
Atlanta, GA
Received
Apr 15, 2024
Decided
Aug 29, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100045

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MOM

FDA's approval statement

As written in FDA's record.

two additional sites, Abbott Pleasanton and San Ramon, for manufacturing, servicing and/or receiving inspection for the CardioMEMS Hospital System

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.